236例弥漫大B细胞淋巴瘤患者临床特点及预后因素分析
被引量:10
摘要
弥漫大B细胞淋巴瘤(DLBCL)是中老年人群中最常见的一种侵袭性非霍奇金淋巴瘤(NHL),通过联合化疗后有近半数以上的患者可长期存活,但仍有相当一部分患者因淋巴瘤进展而死亡。如何进一步评估DLBCL患者的预后,以及采用生物学分型和制定个体化治疗方案是当前研究的热点之一。DLBCL的临床预后评估目前仍采用国际预后指数(IPI),
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2012年第9期768-770,共3页
Chinese Journal of Hematology
参考文献14
-
1Cheson BD, Homing SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin' s lym- phomasc. NCI Sponsored International Working Group. J Clin On- col, 1999, 17:1244.
-
2Hans CP,Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immu- nohistochemistry using a tissue microarray. Blood, 2004, 103 : 275 -282.
-
3Coiffier B. Non-Hodgkin' s lymphomas. In:Cavalli F, Hansen HH, Kaye SB, eds. Textbook of medical oncology. London : Martin Dun- itz, 1997:265-287.
-
4A predictive model for aggressive non-Hodgkin' s lymphoma. The International Non-Hodgkin' s Lymphoma Prognostic Factors Pro-ject. N Engl J Med, 1993, 329:987-994.
-
5Effect of age on the characteristics and clinical behavior of non- Hodgkin' s lymphoma patients. The Non-Hodgkin' s Lymphoma Classification Project. Ann Onco1,1997,8:973-978.
-
6Gutierrez-Garcia G, Colomo L,Villamor N, et at. Clinico-biological characterization and outcome of primary nodal and extranodal dif- fuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma, 2010, 51:1225-1232.
-
7王晶,克晓燕,赵灵芝,李敏,景红梅,王继军,赵伟,高子芬.74例弥漫大B细胞淋巴瘤的预后相关因素分析[J].中华血液学杂志,2007,28(10):667-670. 被引量:17
-
8Sehn LH, Berry B, Chhanabhai M, et al. The revised Internation- al Prognostic Index (R-IPI) is a better predictor of outcome than standard IPI for patients with diffuse large B-cell Lymphoma treated with R-CHOP. Blood, 2007, 109:1857-1861.
-
9Alizadeh AA,Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 2000, 403:503-511.
-
10Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large cell lymphoma. N Engl J Med, 2002, 346 : 1937-1947.
二级参考文献11
-
1王苗,李敏,韩志惠,高子芬.胃肠道黏膜相关淋巴组织淋巴瘤BCL-10的表达[J].中华血液学杂志,2004,25(10):592-595. 被引量:1
-
2闵大六,夏海龙,周晓燕,孙孟红,杨文涛,张太明,郑爱华,施达仁.弥漫大B细胞淋巴瘤组织bcl-6蛋白表达及基因重排[J].中华病理学杂志,2005,34(6):327-331. 被引量:4
-
3翁阳,高子芬,刘侃,张伟京,克小燕,李敏.弥漫性大B细胞淋巴瘤预后相关因素的研究[J].中华内科杂志,2005,44(9):681-683. 被引量:10
-
4Zhang A, Ohshima K, Kikuchi M, et al. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas. Pathol Int, 1999, 49:1043-1052.
-
5Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 2000, 403:503-511.
-
6Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med, 2002, 346:1937-1947.
-
7Shipp MA, Ross KN, Golub TR. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med, 2002, 8:68-74.
-
8Hans CP, Weisenburger DD, Chan WC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 2004,103:275-282.
-
9Chang CC, McClintock S, Perkins SL, et al expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol, 2004, 28:464-470.
-
10Barrans SL, Carter I, Owen RG, et al. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood, 2002, 99:1136-1143.
共引文献16
-
1杨艳丽,王晶,赵灵芝,高子芬,景红梅,克晓燕.40例原发性胃肠道弥漫大B细胞淋巴瘤临床特征、细胞来源与预后分析[J].癌症,2008,27(6):636-641. 被引量:12
-
2徐方平,刘艳辉,骆新兰,庄恒国,李丽,罗东兰,许洁,张芬,张明辉,杜欣,李文瑜.弥漫性大B细胞淋巴瘤各分子亚型中的bcl-6基因重排与蛋白表达的临床意义[J].中华病理学杂志,2008,37(6):371-376. 被引量:11
-
3魏蓉,张燕香,孟月生.弥漫性大B细胞淋巴瘤的临床特征及相关因素分析[J].同济大学学报(医学版),2008,29(6):79-81.
-
4林雯,李蔚冰,林英城,王鸿彪,林文照,林穗玲.弥漫大B细胞淋巴瘤挽救化疗的疗效及预后分析[J].实用临床医药杂志,2010,14(7):83-84. 被引量:1
-
5谢昊,章璐,王丽英.弥漫大B细胞淋巴瘤误诊为多发性肌炎1例并文献复习[J].中日友好医院学报,2011,25(4):236-237.
-
6李佳,胡荣,廖爱军,石卉莹,杨威,刘卓刚.非霍奇金淋巴瘤中增殖指数Ki-67及其临床价值[J].中国实验血液学杂志,2011,19(4):935-939. 被引量:14
-
7元建华,彭小东,黎军和.原发性胃弥漫大B细胞淋巴瘤82例预后分析[J].实用医学杂志,2011,27(22):4124-4126. 被引量:1
-
8双跃荣,黃晖,李午平,黄燕.70例结内弥漫大B细胞淋巴瘤的临床特征、免疫亚型与预后分析[J].中国癌症杂志,2011,21(9):696-700. 被引量:2
-
9刘爱学,张容榕,李明淑,周泽强,冯天举.R-CHOP方案初治CD20阳性弥漫大B细胞淋巴瘤的临床疗效评价[J].肿瘤预防与治疗,2012,25(4):246-248. 被引量:1
-
10李吉满,何先慧,侯俊,万俊峰,汤梅,王影.头颈部弥漫大B细胞淋巴瘤的免疫组织化学分型分析[J].肿瘤预防与治疗,2013,26(4):208-212.
同被引文献87
-
1李京京,顼晋昆,李莉.EB病毒阳性的扁桃体溃疡临床特征分析[J].山东大学耳鼻喉眼学报,2020,34(1):58-62. 被引量:1
-
2崔旭,邓长安,刘霆,孟文彤,徐才刚,粟军.血管内大B细胞淋巴瘤1例报告并文献复习[J].临床血液学杂志,2005,18(3):161-163. 被引量:8
-
3钟艳平,杨华,王连有,刘学娟.儿童扁桃体原发性恶性B细胞淋巴瘤临床病理观察[J].诊断病理学杂志,2005,12(5):350-352. 被引量:3
-
4周立强,孙燕,谭文勇,李陶,王琦路,冯凤仪,王金万,储大同,石远凯,李晔雄,孙云田,吕宁.非霍奇金淋巴瘤1125例临床病理分析[J].癌症进展,2006,4(5):391-397. 被引量:47
-
5Shiramizu B, Goldman S, Kusao I, et al. Minimal disease assess- ment in the treatment of children and adolescents with intermediate-risk ( Stage 111/IV ) B-cell non-Hodgkin lymphoma: a children's oncology group report. Br J Haematol, 2011, 153: 758-763.
-
6Alfred R, Wolfram K. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol, 2008, 142: 329-347.
-
7Murphy SB. Classification, staging and end resuhs of treatment of childhood non-Hodgkin' s lymphomas: dissimilarities from lympho- mas in adults. Semin Oncol, 1980,7: 332-339.
-
8Cheson B, Pfistner B, Juweid M, et al. Revised reponse criteria for malignant lymphoma. J Clin Oncol, 2007,25 : 579-586.
-
9Catherine P, Anne A, Mary G, et al. Results of the randomizedinternational FAB/LMB96 trial for intermediate risk B-cell non- Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood, 2007, 109 : 2773-2780.
-
10Oschlies I, Burkhardt B, Salaverria I, et al. Clinical, pathologi- cal and genetic features of primary mediastinal large B-cell lympho- mas and mediastinal gray zone lymphomas in children. Haemato- logica, 2011,96: 262-268.
引证文献10
-
1杨英,张洁,陈芳.弥漫大B细胞淋巴瘤的临床特点及预后影响因素分析[J].湖南师范大学学报(医学版),2021,18(5):138-140. 被引量:5
-
2叶启东,潘慈,薛惠良,陈静,周敏,江华,沈树红,汤燕静,王坚敏,汤静燕.104例B细胞非霍奇金淋巴瘤患儿疗效分析[J].中华血液学杂志,2013,34(5):399-403. 被引量:10
-
3徐海燕,张凤春,林玉梅.198例弥漫大B细胞淋巴瘤临床特征及预后因素分析[J].上海交通大学学报(医学版),2014,34(11):1618-1621. 被引量:2
-
4姜健,宋学文,徐慧娟,仲任,泥永安,孙立荣.儿童非霍奇金淋巴瘤78例临床及预后分析[J].临床儿科杂志,2015,33(8):715-719. 被引量:8
-
5郭军,林兰意,王岚,余敏杰,徐玉敏,诸葛传德,谢青,王晖.以肝损害为首发表现的血管内大B细胞淋巴瘤1例[J].肝脏,2016,21(1):79-80. 被引量:1
-
6佟丹江.弥漫大B细胞淋巴瘤的流行病学分析[J].中国现代药物应用,2016,10(8):46-47. 被引量:20
-
7徐丽,黄竞,海热萨·阿不力米提,穆妮热·艾尼,巴哈古丽·玉素甫,马平,王雯倩,李黎,岳金芳.维吾尔族非霍奇金淋巴瘤患者遗传学特点对不同化疗方案的疗效分析[J].世界中医药,2016,11(B06):2220-2221.
-
8薛久巍,于生龙,马德爽,陈光.惰性B细胞淋巴瘤的临床特点与生存状况研究[J].中国医药科学,2017,7(5):158-160. 被引量:2
-
9赵兴贺,樊明月,窦训武,贾广彪.儿童原发扁桃体弥漫大B细胞淋巴瘤1例并文献复习[J].山东大学耳鼻喉眼学报,2022,36(1):120-124. 被引量:1
-
10廖子君,孙海凤,苏智祥,郑琪,郭亚焕.CHOP序贯GDP初始治疗侵袭性非霍奇金淋巴瘤的临床观察[J].现代医学,2019,47(3):245-250. 被引量:2
二级引证文献50
-
1张梦,金玲,杨菁,段彦龙,黄爽,周春菊,张永红.改良LMB 89 C组方案治疗儿童高危伯基特淋巴瘤172例临床分析[J].中华血液学杂志,2019,40(8):633-638. 被引量:8
-
2陶盛能,王小华,赵敏,邹昭玲,王尚君,倪平,张伶伶,程之明.利妥昔单抗联合化疗对惰性B细胞淋巴瘤的疗效分析[J].肿瘤学杂志,2018,24(12):1191-1195. 被引量:2
-
3万鑫,王书楠,国巍,唐杨,王兴彤,刘明锁,白鸥.^(18)F-FDG PET/CT对98例惰性B细胞淋巴瘤预后评估[J].第三军医大学学报,2019,41(4):366-370. 被引量:2
-
4周峻,陈芳林,王浩,姜斌,李涛,易军,刘继炎,武海燕,唐英姿.肠套叠为首发表现儿童原发性胃肠道淋巴瘤临床特征分析[J].中华肿瘤防治杂志,2015,22(19):1561-1565. 被引量:10
-
5伞景辉,谭天海.骨原发非霍奇金淋巴瘤1例并文献复习[J].中外医学研究,2016,14(1):163-164. 被引量:1
-
6许京淑,李松,陈杨杨,徐奔,向航.利妥昔单抗治疗非霍奇金淋巴瘤的远期疗效及其对免疫水平的影响[J].疑难病杂志,2016,15(10):1048-1051. 被引量:10
-
7黄盛才,丁义,秦朝军,章忠明,龙耀斌,马加强,颜李梅.弥漫大B细胞淋巴瘤^(18)F-FDG PET/CT的显像特征及其诊断价值[J].山东医药,2017,57(2):1-4. 被引量:11
-
8李清平,刘洁,黎艳,肖波.弥漫大B细胞淋巴瘤组织中Bcl-2、NF-κB、C-myc蛋白表达及临床意义[J].国际检验医学杂志,2017,38(10):1370-1372. 被引量:2
-
9江莲,侯媛媛,张文婷,朱秀丽.地高辛对非霍奇金淋巴瘤细胞体外药物敏感性的研究[J].中国小儿血液与肿瘤杂志,2017,22(3):116-122. 被引量:1
-
10丁义,黄盛才,秦朝军,章忠明,龙耀斌,马加强,颜李梅.^(18)F-氟代脱氧葡萄糖正电子发射断层成像/CT与同机CT对弥漫大B细胞淋巴瘤患者淋巴结及结外病灶的诊断价值对比[J].广西医学,2017,39(7):933-936. 被引量:2
-
1贾柳萍,章天予,黄日允,李彤,陈为.慢性胃炎、胃癌细胞增殖与癌胚抗原关系探讨[J].广东医学,1990,11(5):28-29.
-
2徐惠绵.胃癌D2手术基础上的个体化治疗策略[J].中华医学信息导报,2014,0(22):15-15.
-
3吴小剑,詹文华.胃癌的分型与临床应用[J].中国现代手术学杂志,2002,6(2):157-158. 被引量:3
-
4李德昌,赵瑞敏,任力,岳颖,毛志远.胃肠道间质瘤的临床病理分析[J].内蒙古中医药,2008,27(8X):51-53. 被引量:2
-
5田晨,朱磊,王超雨,于泳,张翼鷟.高危急性髓系白血病的诊疗进展[J].山东医药,2015,55(34):94-96. 被引量:3